Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 56.65M | 48.94M | 34.22M | 23.75M | 15.50M | 7.42M |
Gross Profit | 42.68M | 36.76M | 23.13M | 14.65M | 9.32M | 2.88M |
EBITDA | 16.02M | 6.27M | -5.77M | -3.20M | -5.11M | -2.30M |
Net Income | 476.72K | -7.73M | -14.12M | -9.15M | -9.86M | -5.88M |
Balance Sheet | ||||||
Total Assets | 134.67M | 124.58M | 64.50M | 50.41M | 51.28M | 33.80M |
Cash, Cash Equivalents and Short-Term Investments | 66.77M | 58.89M | 15.25M | 12.28M | 21.56M | 8.66M |
Total Debt | 30.66M | 29.26M | 28.17M | 7.09M | 7.86M | 9.52M |
Total Liabilities | 68.29M | 59.51M | 49.73M | 24.43M | 17.09M | 14.59M |
Stockholders Equity | 66.38M | 65.07M | 14.76M | 25.98M | 34.19M | 19.21M |
Cash Flow | ||||||
Free Cash Flow | -5.54M | -10.09M | -18.39M | -9.82M | -7.74M | -9.28M |
Operating Cash Flow | 15.31M | 9.79M | -1.28M | 2.99M | 2.31M | -1.98M |
Investing Cash Flow | -18.94M | -17.52M | -15.97M | -11.91M | -10.04M | -6.43M |
Financing Cash Flow | 30.23M | 50.62M | 20.27M | -383.91K | 21.20M | 13.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
59 Neutral | 698.80M | 124.81 | 2.71% | ― | 41.68% | -16.15% | |
55 Neutral | 8.46M | -1.43 | 0.00% | ― | -72.12% | 40.30% | |
55 Neutral | C$530.33M | 1,031.48 | 0.99% | ― | 39.32% | ― | |
46 Neutral | 27.50M | -5.47 | -1838.81% | ― | -47.10% | -19.32% | |
34 Underperform | 13.36M | -2.22 | 0.00% | ― | 0.00% | 21.61% | |
34 Underperform | 54.66M | -4.15 | 0.00% | ― | 0.00% | 40.17% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Kneat Solutions announced its participation in the Emerging Growth Conference on September 24, 2025, where CEO Eddie Ryan will present the company’s recent progress and engage with investors in a live, interactive session. This event highlights Kneat’s ongoing commitment to innovation in digital validation, reinforcing its position as a key player in the life sciences industry by providing solutions that reduce risk and accelerate product market entry.
The most recent analyst rating on (TSE:KSI) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on kneat.com stock, see the TSE:KSI Stock Forecast page.
Kneat.com has secured a three-year Master Services Agreement with a major European equipment manufacturer, marking its seventh strategic customer win in 2025. This agreement will see the implementation of the Kneat Gx platform to digitize the manufacturer’s equipment testing processes, enhancing quality and client handover, and is part of Kneat’s ongoing success in expanding digital capabilities across industries.
The most recent analyst rating on (TSE:KSI) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on kneat.com stock, see the TSE:KSI Stock Forecast page.
Kneat.com has secured a three-year Master Services Agreement with a major global medical technology company, a division of a larger Asian manufacturer. This agreement will see the implementation of Kneat’s Gx platform for equipment validation, further solidifying Kneat’s position in the life sciences sector. The adoption by large-scale life sciences companies highlights Kneat’s technical capabilities and the strategic trust placed in their platform.
The most recent analyst rating on (TSE:KSI) stock is a Buy with a C$4.90 price target. To see the full list of analyst forecasts on kneat.com stock, see the TSE:KSI Stock Forecast page.
Kneat.com announced a record revenue of $15.4 million for the second quarter of 2025, marking a 32% increase from the previous year. The company’s gross margin reached 75%, and its annual recurring revenue grew by 43% to $64.8 million. These financial results highlight Kneat’s strong market position and the growing adoption of its Kneat Gx platform. The company has also expanded its executive leadership team and secured significant agreements with multinational companies, further solidifying its presence in the industry.
The most recent analyst rating on (TSE:KSI) stock is a Buy with a C$4.90 price target. To see the full list of analyst forecasts on kneat.com stock, see the TSE:KSI Stock Forecast page.